A Double-blind, Randomized, Placebo-controlled Study to Evaluate Two Treatment Regimens of Cat-PAD in Cat Allergic Subjects Following Challenge to Cat Allergen in an Environmental Exposure Chamber.

Trial Profile

A Double-blind, Randomized, Placebo-controlled Study to Evaluate Two Treatment Regimens of Cat-PAD in Cat Allergic Subjects Following Challenge to Cat Allergen in an Environmental Exposure Chamber.

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Apr 2015

At a glance

  • Drugs Cat SPIRE (Primary)
  • Indications Hypersensitivity; Rhinoconjunctivitis
  • Focus Therapeutic Use
  • Sponsors Circassia
  • Most Recent Events

    • 30 Apr 2015 Last checked against ClinicalTrials.gov record (Extension trial, NCT01604018).
    • 30 Apr 2015 Last checked against ClinicalTrials.gov record (Extension trial, NCT01604018).
    • 30 Apr 2015 Last checked against ClinicalTrials.gov record (Extension trial, NCT01604018).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top